Maravai LifeSciences Holdings, Inc. (MRVI) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGS. Market cap 2.67B USD. 52-week range 2.54 to 9.42 USD. Data as of 2026-10-09.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, and oligonucleotide therapy, as ...